Global Dry Powder Inhaler Market (2016-2024)- Research Nester


Dry Powder Inhaler is referred to a device that helps to deliver medication to the lungs in the form of dry powder. Dry powder inhaler is widely used to treat respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD) and others. Dry powder inhaler is very easy and convenient way to deliver medicine into human being.

Market Size and Forecast

Global Dry Powder Inhaler Market is expected to grow at a robust growth over the forecast period i.e. 2017-2024. Further, the market of dry powder inhaler is riding on the back of various factors such as growing prevalence of respiratory diseases such as asthma and others. Moreover, rising demand for advanced healthcare devices for the treatment of chronic diseases is envisioned to boost the demand for dry powder inhaler.

On the basis of application, the global dry powder inhaler market is segmented into asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, cardiovascular disease, diabetes and others. Moreover, asthma segment captured the largest market of overall dry powder inhaler market in 2016. Likely, this growth of asthma segment is attributed to the growing asthma affected population.

In terms of regional platform, North America is expected to capture the largest share of the global dry powder inhaler market as they are early adopters of advance healthcare technologies. Additionally, U.S. is anticipated to be the major contributor towards the growth of dry powder inhaler market owing to increasing research and development activities related to healthcare devices. Moreover, presence of major key players of dry powder inhaler such as Mannkind Corporation is believed to flourish the growth of   dry powder inhaler market in North America region.

For Sample Pages please go through link below:

http://www.researchnester.com/sample-request/2/rep-id-481

Europe region accounted the second largest market of dry powder inhaler in terms of revenue in 2016. Moreover, increasing asthma patients and rising government healthcare investment are the factors propelling the growth of dry powder inhaler market in Europe region. Asia-Pacific region is expected to showcase a highest CAGR over the forecast period due to emerging economies nations such as China and India. Moreover, Japan and China are the dominating country in this region owing to growing geriatric population and rising disposable income of the population.

Market Segmentation

Our in-depth analysis segmented the global dry powder inhaler market in the following segments:

By Type

Single dose

Multi-dose

By Application

Asthma

Chronic Obstructive Pulmonary Disease (COPD)

Cystic Fibrosis

Cardiovascular Disease

Diabetes 

Others

By End-User

Hospitals & Clinics

Homecare

By Region

Global dry powder inhaler market is further classified on the basis of region as follows:

North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis

Latin America (Brazil, Mexico, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis

Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis

Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of Asia) Market size, Y-O-Y growth & Opportunity Analysis.

Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis

Growth Drivers and Challenges

Factors such as growing adoption of unhealthy lifestyle, rising geriatric population, rising exposure to smoke & chemicals and increase in the prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD and others are believed to be the dynamic factor behind the rapid growth of dry powder inhaler market across the globe. Further, favorable government initiatives to improve healthcare infrastructure is envisioned to bolster the growth of dry powder inhaler market by the end of 2024.

Request For TOC Here:

http://www.researchnester.com/toc-request/1/rep-id-481

Moreover, rising disposable income along with increasing adoption of innovative healthcare devices is predicted to fuel the growth of dry powder inhaler market. Likely, rapid urbanization and growing GDP figures of the developed and developing nations are also projected to flourish the growth of dry powder inhaler market. In addition to this, rising healthcare expenditure across the globe is also believed to elevate the growth of dry powder inhaler market.

However, lack of awareness regarding dry powder inhaler is expected to hamper the growth of dry powder inhaler market over the forecast period.

Key players

The major key players for dry powder inhaler market are as follows

Mannkind Corporation

Company Overview

Key Product Offerings

Business Strategy

SWOT Analysis

Financials

Cipla Inc.

Hovione FarmaCiencia SA

GlaxoSmithKline Plc.

Meda Pharmaceuticals Inc.

3M Company

AstraZeneca Plc.

Vectura Group Plc.

Teicos Pharma Ltd

Teva Pharmaceutical Industries

Scope and Context

Overview of the Parent Market

Analyst View

Segmentation

The global dry powder inhaler market is segmented as follows:

By Type Market Size & Y-O-Y Growth Analysis

By Application Market Size & Y-O-Y Growth Analysis

By Region Market Size & Y-O-Y Growth Analysis

Market Dynamics

Supply & Demand Risk

Competitive Landscape

Porter’s Five Force Model

Geographical Economic Activity

Key Players (respective SWOT Analysis) and their Strategies and Product Portfolio

Recent Trends and Developments

Industry Growth Drivers and Challenges

Key Information for Players to establish themselves in current dynamic environment

 

To know more about this research, kindly visit:

http://www.researchnester.com/reports/dry-powder-inhaler-market-global-historical-growth-2012-2016-future-outlook-2017-2024-demand-analysis-opportunity-evaluation/481

 

For Table of Content & Free Sample Report Contact:

Name:- Ajay Daniel

Email: ajay.daniel@researchnester.com                                       

U.S. +1 646 586 9123

U.K. +44 203 608 5919

Website:- www.researchnester.com



Report Abuse     Posted By Den Mark
©2014 News Liner. All rights reserved - Terms of Use | Privacy Policy | Help
Dessigned By The Colour Moon
social share buttons code